Operating, investing, and financing cash movements
DexCom generated $1.8B in operating cash flow over the trailing twelve months. After $353.1M in capital expenditures, free cash flow was $1.4B. Free cash flow increased 1.5% year-over-year. Based on the Q1 2026 filing.